DE69534258D1 - Verfahren zur Stabilisierung von Pranoprofen und stabile flüssige Zubereitung von Pranoprofen - Google Patents

Verfahren zur Stabilisierung von Pranoprofen und stabile flüssige Zubereitung von Pranoprofen

Info

Publication number
DE69534258D1
DE69534258D1 DE69534258T DE69534258T DE69534258D1 DE 69534258 D1 DE69534258 D1 DE 69534258D1 DE 69534258 T DE69534258 T DE 69534258T DE 69534258 T DE69534258 T DE 69534258T DE 69534258 D1 DE69534258 D1 DE 69534258D1
Authority
DE
Germany
Prior art keywords
pranoprofen
aqueous solution
liquid preparation
stabilization
stable liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69534258T
Other languages
English (en)
Other versions
DE69534258T2 (de
Inventor
Koji Doi
Hisako Sawa
Yoshie Ozaki
Yoshiyuki Kimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Mitsubishi Pharma Corp
Original Assignee
Senju Pharmaceutical Co Ltd
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd, Mitsubishi Pharma Corp filed Critical Senju Pharmaceutical Co Ltd
Publication of DE69534258D1 publication Critical patent/DE69534258D1/de
Application granted granted Critical
Publication of DE69534258T2 publication Critical patent/DE69534258T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
    • Y10T428/139—Open-ended, self-supporting conduit, cylinder, or tube-type article
    • Y10T428/1393—Multilayer [continuous layer]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69534258T 1994-03-15 1995-03-14 Verfahren zur Stabilisierung von Pranoprofen und stabile flüssige Zubereitung von Pranoprofen Expired - Lifetime DE69534258T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4418494 1994-03-15
JP4418494 1994-03-15

Publications (2)

Publication Number Publication Date
DE69534258D1 true DE69534258D1 (de) 2005-07-14
DE69534258T2 DE69534258T2 (de) 2006-05-04

Family

ID=12684495

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69534258T Expired - Lifetime DE69534258T2 (de) 1994-03-15 1995-03-14 Verfahren zur Stabilisierung von Pranoprofen und stabile flüssige Zubereitung von Pranoprofen

Country Status (19)

Country Link
US (2) US5856345A (de)
EP (2) EP1163906A3 (de)
KR (1) KR100338851B1 (de)
CN (1) CN1091597C (de)
AT (1) ATE297206T1 (de)
AU (1) AU707119B2 (de)
BR (1) BR9501081A (de)
CA (1) CA2144591A1 (de)
DE (1) DE69534258T2 (de)
EE (1) EE9500015A (de)
ES (1) ES2240966T3 (de)
FI (1) FI951190A (de)
HU (1) HUT71245A (de)
LT (1) LT3969B (de)
LV (1) LV10922B (de)
NO (1) NO950970L (de)
PL (1) PL179534B1 (de)
RU (1) RU2148402C1 (de)
TW (1) TW358812B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235781B1 (en) 1998-07-14 2001-05-22 Alcon Laboratories, Inc. Prostaglandin product
WO2000032157A1 (en) * 1998-12-02 2000-06-08 Copa Distributors, Llc Gradual hair relaxation composition
US8877168B1 (en) 2002-07-31 2014-11-04 Senju Pharmaceuticals Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
WO2004010974A2 (en) * 2002-07-31 2004-02-05 Pharmacia Corporation Gelatin capsule exhibiting reduced cross-linking
EP1525884B1 (de) * 2002-07-31 2011-10-12 Senju Pharmaceutical Co., Ltd. Wässrige, flüssigkeitszubereitungen und lichtstabilisierte wässrige flüssigkeitszubereitungen
ES2301964T3 (es) 2003-01-21 2008-07-01 Senju Pharmaceutical Co., Ltd. Preparado liquido acuoso que contiene acido 2-amino-3-(4-bromobenzoil)fenilacetico.
CA2521603A1 (en) * 2003-04-07 2004-10-21 Jurox Pty Ltd Stable carprofen composition
US7125497B1 (en) * 2003-05-22 2006-10-24 Sandia Corporation Reactive formulations for a neutralization of toxic industrial chemicals
WO2004112837A1 (ja) * 2003-05-23 2004-12-29 Hisamitsu Pharmaceutical Co., Inc. 非ステロイド系消炎鎮痛剤含有外用経皮製剤およびインターロイキン－１α生成抑制剤
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
CN104010661B (zh) * 2011-12-27 2017-06-06 千寿制药株式会社 含有二丁基羟基甲苯的制剂及二丁基羟基甲苯的稳定化方法
IN2014MN01555A (de) * 2012-02-27 2015-07-03 Rohto Pharma
WO2014129466A1 (ja) * 2013-02-19 2014-08-28 ロート製薬株式会社 網膜疾患の予防、改善、又は治療用粘膜適用剤
JP5340498B1 (ja) * 2013-03-11 2013-11-13 千寿製薬株式会社 ソフトコンタクトレンズ用眼科用組成物
RU2674657C2 (ru) * 2013-05-30 2018-12-12 Сэндзю Фармасьютикал Ко., Лтд. Способ стабилизации хлорфенирамина и его соли
TWI644663B (zh) * 2014-03-10 2018-12-21 日商千壽製藥股份有限公司 二丁基羥基甲苯的穩定化方法，及含二丁基羥基甲苯之製品(一)
TW201540292A (zh) * 2014-03-10 2015-11-01 Senju Pharma Co 二丁基羥基甲苯的穩定化方法（二）
AR102172A1 (es) 2015-10-05 2017-02-08 Química Luar S R L Una composición farmacéutica bactericida y virucida
KR102478553B1 (ko) * 2018-02-28 2022-12-16 한림제약(주) 벤조피란 유도체 또는 이의 약학적으로 허용가능한 염을 포함하는 용액 형태의 점안제
CN115677733A (zh) * 2022-12-20 2023-02-03 济南宣正药业有限公司 一种用于普拉洛芬质量研究的化合物及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931295A (en) 1974-07-23 1976-01-06 Universal Oil Products Company Hydroxylation of aromatic compounds
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
US4565851A (en) * 1983-04-25 1986-01-21 Eastman Kodak Company Containers having improved gas barrier properties
US4525348A (en) * 1983-12-19 1985-06-25 Yoshitomi Pharmaceutical Industries, Ltd. Pranoprofen gelled ointment
JPS60184013A (ja) 1984-03-01 1985-09-19 Yoshitomi Pharmaceut Ind Ltd 点眼剤
JPS61130222A (ja) * 1984-11-30 1986-06-18 Kureha Chem Ind Co Ltd 抗腫瘍剤
US4940728A (en) * 1985-05-17 1990-07-10 Postley John E Treatment for sino-nasal congestion
US5110492A (en) * 1985-05-24 1992-05-05 Irene Casey Cleaner and disinfectant with dye
US5032392A (en) * 1986-09-04 1991-07-16 Vision Pharmaceuticals Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
US5414011A (en) * 1987-09-11 1995-05-09 Syntex (U.S.A.) Inc. Preservative system for ophthalmic formulations
US5110493A (en) * 1987-09-11 1992-05-05 Syntex (U.S.A.) Inc. Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
AU634358B2 (en) * 1990-03-02 1993-02-18 Shiseido Company Ltd. Oil-in-water emulsion composition containing nonsteroidal antiphlogistic analgesic
TW206918B (de) * 1991-05-11 1993-06-01 Kuko Seiyaku Kk
JPH05124092A (ja) * 1991-11-06 1993-05-21 Chisso Corp ポリオレフイン系樹脂製中空容器
CA2153553A1 (en) * 1994-07-13 1996-01-14 Hidekazu Suzuki Stable lipid emulsion

Also Published As

Publication number Publication date
KR100338851B1 (ko) 2002-10-12
LT3969B (en) 1996-05-27
LT95028A (en) 1995-10-25
US5889030A (en) 1999-03-30
LV10922A (lv) 1995-12-20
KR950032201A (ko) 1995-12-20
TW358812B (en) 1999-05-21
CA2144591A1 (en) 1995-09-16
DE69534258T2 (de) 2006-05-04
EE9500015A (et) 1995-12-15
EP0672414B1 (de) 2005-06-08
RU2148402C1 (ru) 2000-05-10
FI951190A (fi) 1995-09-16
AU1485295A (en) 1995-09-21
HU9500772D0 (en) 1995-04-28
AU707119B2 (en) 1999-07-01
ES2240966T3 (es) 2005-10-16
ATE297206T1 (de) 2005-06-15
FI951190A0 (fi) 1995-03-14
NO950970L (no) 1995-09-18
PL179534B1 (pl) 2000-09-29
CN1111510A (zh) 1995-11-15
LV10922B (en) 1996-08-20
NO950970D0 (no) 1995-03-14
US5856345A (en) 1999-01-05
PL307671A1 (en) 1995-09-18
EP1163906A3 (de) 2003-05-21
CN1091597C (zh) 2002-10-02
EP0672414A2 (de) 1995-09-20
BR9501081A (pt) 1996-06-04
EP0672414A3 (de) 1995-12-13
HUT71245A (en) 1995-11-28
EP1163906A2 (de) 2001-12-19

Similar Documents

Publication Publication Date Title
DE69534258D1 (de) Verfahren zur Stabilisierung von Pranoprofen und stabile flüssige Zubereitung von Pranoprofen
ATE120960T1 (de) Stabile injizierbare lösungen von faktor viii.
DE69022345T2 (de) Verfahren zur Entwicklung von Chlordioxyd und Zusammensetzungen für die Desinfektion.
PT1427395E (pt) Estabilização de agentes activos por formulação sob uma forma nanoparticulada
ATE184289T1 (de) Ribosomen-inaktivierende proteine, inaktive vorläuferformen derselben, verfahren zur herstellung und eine methode zur nutzung
DE217379T1 (de) Thrombolytische zusammensetzung und verfahren zu deren herstellung.
ATE42206T1 (de) Verfahren und zusammensetzung zur gleichzeitigen reinigung und desinfektion von kontaktlinsen.
DE69926030D1 (de) Verfahren zur vor Ort Herstellung eines desinfizierenden Peressigsäuresystems
ATE340798T1 (de) Stabile, flüssige konzentrierte seltenerd- carboxylate
DE69231235T2 (de) Verfahren zur Herstellung von Perfluoropolyoxyalkylenen mit hoher Viskosität und niedrigem Peroxidsauerstoffgehalt
ATE287255T1 (de) Stabile flüssigkeiten mit hohem glycerolgehalt, die sulfosuccinsäuremonoester enthalten
DE69200250T2 (de) Verfahren zur verlängerung der gaslebensdauer von excimer-lasern.
DE69416764T2 (de) Verfahren zur Stabilisierung eines Kontaktlinsenpräparats
DE59708046D1 (de) Verfahren zur Herstellung von Celluloselösungen in wasserhaltigem Aminoxid
ATE76307T1 (de) Bakterizide zusammensetzung zur entkeimung von kontaktlinsen oder aehnlichen produkten in waessrigem medium.
DE69422738T2 (de) Verfahren und vorrichtung zur weinsteinstabilisierung von wein
DE69207481D1 (de) Verfahren zur Stabilisierung von wässeriger Acrylamidlösung
DE59901162D1 (de) Verfahren zur Stabilisierung von Cyanhydrinen
DE69433223D1 (de) Behandlungsverfahren von Geflügelkörpern zur Verlängerung der Haltbarkeit und Einschränkung des Salmonellen-Wachstums
DE3789523D1 (de) Verfahren zur Stabilisierung des Lactoperoxidase-Enzyms in Produkten.
ATE31245T1 (de) Verfahren zur stabilisierung von haematin.
DE59501234D1 (de) Verfahren zur Herstellung von 2-Nitrobenzaldehyden
DE60004457D1 (de) Verfahren zur Verlängerung der Haltbarkeit von Schnittblumen
DE59304167D1 (de) Mikrobiologisches Verfahren zur Herstellung von 5-Hydroxy-2-pyrazincarbonsäure
ATE69137T1 (de) Stabilisiertes gossyplure und verfahren zu dessen herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition